The relationship between shortened electromechanical systole (QS2I) and 24-hour urinary catecholamine excretion (E + NE) was 
ine excretion
Systolic time intervals that beta-adrenergic stimulation shortens electromechanical systole in man and animals. [9] [10] [11] [12] [13] [14] Patients with acute myocardial infarction frequently exhibit excessive adrenergic activity as evidenced by an elevation of plasma and 24-hour urinary catecholamines. [15] [16] [17] [18] [19] [20] [21] [22] [23] It was therefore hypothesized that the abbreviated electromechanical systole characteristic of patients with myocardial infarction is a direct reflection of increased sympathetic nervous system activity. The.present investigation was designed to test this hypothesis. http://circ.ahajournals.org/ Downloaded from returned toward or became normal by the time of discharge in those subjects with a follow-up study. An abnormally increased PEP/LVET suggesting left ventricular dysfunction was initially present in 10 subjects in group I and 14 in group II. However, the correlations between E + NE and PEP/LVET for each group (r=0.02 and r=-0.14) as well as for the combined group (r = -0.09) were not significant.
Although several patients with elevated urinary NE + E excretion exhibited clinical signs of increased adrenergic tone, these signs were not consistently present. This was particularly true after the first day of hospitalization. Thus, no relationship between E + NE excretion and either heart rate or blood pressure could be demonstrated in either group I or II. Figure 3 illustrates serial studies in one patient with an acute myocardial infarction who suffered an extension of his infarction on the seventh hospital day. It can be seen that the changes in QS2I and E + NE excretion were closely associated.
The effect of a small intravenous dose (2.5 mg) of the beta-adrenergic blocking agent propranolol upon the QS2I was studied in 13 patients in whom the QS2I was short and urinary catecholamines elevated (seven from group I and six from group II). These results were contrasted to results from eight normal volunteers ( fig. 4) . In normal subjects this dose of propranolol caused no significant change in the QS2I. However, in the 13 patients with a short QS2I there was a lengthening in each instance, although the QS2I remained abnormally short (less than 2 SD of normal QS2I) in four of 13. The mean increase after 15 min was 14 msec± 5.3 (P<0.001).
The catecholamine excretion of patients with acute myocardial infarction accompanied by serious arrhythmia (multiple PVCs, ectopic tachycardia of any type) during the time of study is contrasted to those without arrhythmia in figure 5 . In most instances the study was performed prior to the development of the arrhythmia since antiarrythmic therapy usually excluded the patient from study. Both the total E + NE and E were significantly higher in the arrhythmia group. The effect of 2.5 mg of propranolol administered intravenously on the QS2I in 13 patients from groups I and II, and in eight normal volunteers. The mean change in QS2I after 15 min is illustrated for both groups. A significant lengthening occturred in the patients while none occurred in normals. E NE E+NE Figure 5 The association of catecholamine excretion and incidence of significant arrhythmias in 24 patients with acute myocardial infarction (group I). Those 
